Pharma 4.0 projects may have gotten off to a slow start, but they have ramped up recently.
And many of such projects to date have been in the Big Pharma space, according to the CRB’s 2021 Life Sciences Horizons report. “It makes sense because a lot of these digital technologies have a big dollar sign with them and Big Pharma tends to have the funds for that,” said Yvonne Duckworth, senior automation engineer at CRB.
As adoption matures, more startups will likely embrace Pharma 4.0 technologies, Duckworth said. Even cash-strapped startups building new facilities could lay the groundwork for smart factory upgrades in the future. “It’s about being forward-thinking in designing new facilities,” Duckworth said.
[Related: Pharma 4.0: Industry 4.0 Applied t…